Right upper lobe resection assisted by Toumai® endoscopic surgery robot in two patients
- VernacularTitle:国产图迈®微创腔镜手术机器人辅助右肺上叶切除两例
- Author:
Jia HUANG
1
;
Yu TIAN
1
;
Peiji LU
1
;
Long JIANG
1
;
Jiantao LI
1
;
Hongda ZHU
1
;
Hao LIN
1
;
Qingquan LUO
1
Author Information
1. Department of Oncological Surgery, Shanghai Lung Tumor Clinical Medical Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China
- Publication Type:Journal Article
- Keywords:
Toumai® endoscopic surgery robot;
lobectomy;
non-small cell lung cancer;
surgery treatment
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2022;29(04):519-523
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the efficacy and safety of Toumai® endoscopic surgery robot in right upper lobe resection. Methods The clinical data of 2 patients with non-small cell lung cancer who received right upper lobe resection with Toumai® endoscopic surgery robot in Shanghai Chest Hospital, Shanghai Jiao Tong University in November 2021 were retrospectively analyzed. Both patients were male, aged 66 years and 44 years, respectively. Results The operation was successful in both patients with no conversion to thoracotomy, surgical complication or death. The operation time was 65 min and 48 min, and the amount of intraoperative bleeding was 80 mL and 50 mL, respectively. The postoperative hospital stay was 3 days. There was no blood transfusion during the perioperative period. Conclusion The application of Toumai® endoscopic surgery robot in lobectomy is preliminarily proved to be safe and effective. Compared with Da Vinci robotic surgery system, it has similar clear 3D vision and flexible and stable operation, which can become one of the important choices for the new generation of minimally invasive chest surgery.
